Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy

Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision‐making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectom...

Descripción completa

Detalles Bibliográficos
Autores principales: Nefiss, Mouadh, Abid, Hichem, Gharbi, Mohamed Amine, Bouzidi, Ramzi, Teborbi, Anis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666916/
https://www.ncbi.nlm.nih.gov/pubmed/36408090
http://dx.doi.org/10.1002/ccr3.6599
_version_ 1784831608994398208
author Nefiss, Mouadh
Abid, Hichem
Gharbi, Mohamed Amine
Bouzidi, Ramzi
Teborbi, Anis
author_facet Nefiss, Mouadh
Abid, Hichem
Gharbi, Mohamed Amine
Bouzidi, Ramzi
Teborbi, Anis
author_sort Nefiss, Mouadh
collection PubMed
description Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision‐making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis.
format Online
Article
Text
id pubmed-9666916
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96669162022-11-17 Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy Nefiss, Mouadh Abid, Hichem Gharbi, Mohamed Amine Bouzidi, Ramzi Teborbi, Anis Clin Case Rep Case Report Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision‐making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis. John Wiley and Sons Inc. 2022-11-15 /pmc/articles/PMC9666916/ /pubmed/36408090 http://dx.doi.org/10.1002/ccr3.6599 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Nefiss, Mouadh
Abid, Hichem
Gharbi, Mohamed Amine
Bouzidi, Ramzi
Teborbi, Anis
Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
title Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
title_full Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
title_fullStr Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
title_full_unstemmed Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
title_short Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
title_sort bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666916/
https://www.ncbi.nlm.nih.gov/pubmed/36408090
http://dx.doi.org/10.1002/ccr3.6599
work_keys_str_mv AT nefissmouadh bonemetastasesfromrenalcellcarcinoma4yearsafteraggressivesurgeriesandantiangiogenictherapy
AT abidhichem bonemetastasesfromrenalcellcarcinoma4yearsafteraggressivesurgeriesandantiangiogenictherapy
AT gharbimohamedamine bonemetastasesfromrenalcellcarcinoma4yearsafteraggressivesurgeriesandantiangiogenictherapy
AT bouzidiramzi bonemetastasesfromrenalcellcarcinoma4yearsafteraggressivesurgeriesandantiangiogenictherapy
AT teborbianis bonemetastasesfromrenalcellcarcinoma4yearsafteraggressivesurgeriesandantiangiogenictherapy

Ejemplares similares